Glumetza Diabetes Drug Antitrust Conspiracy Class Action

What’s a fair price for a thirty-day supply of the extended-release diabetes medicine Glumetza—generic name metformin? Is it $55 or $2,200? The complaint for this class action alleges that a number of companies conspired to limit the entry of generic versions of Glumetza to the market. The defendants in this antitrust suit are Bausch Health  Read more

Santarus Glumetza Label

Provigil, Nuvigil, Modafinil Antitrust Settlements

An antitrust class action and an antitrust case brought by the California Attorney General (CAAG) on the same topic are being settled at the same time. The suits claim that drug companies conspired to keep prices of the original drug Provigil high by delaying the introduction of generics and (in the CAAG suit) of Nuvigil.  Read more

Rite Aid False “Usual and Customary” Drug Prices Class Action

Pharmacies are supposed to charge insurance companies and customers their “usual and customary” (U&C) price for generic prescription drugs. This is normally the price paid by customers who do not have insurance and who pay cash, but the complaint claims that Rite Aid charges a higher price, in violation of federal and state regulations. The  Read more

EpiPen Pharmacy Benefits ERISA Class Action

Pharmacy benefit managers (PBMs) OptumRX, ExpressScripts, and CVS Caremark have more than $200 billion per year in revenue and control almost 80% of the industry—and the complaint for this class action alleges that they do it by engaging in schemes for their own profit, violating their fiduciary duties to health plan consumers. Over time, the  Read more